Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
39552393
TITLE
The effect of polygenic liability to mental disorders on COVID-19 outcomes in people with depression: the mediating role of anxiety.
ABSTRACT
BACKGROUND NlmCategory: BACKGROUND
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression.
METHODS NlmCategory: METHODS
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes.
RESULTS NlmCategory: RESULTS
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes. None of the selected PRS predicted SARS-CoV-2 infection or long COVID. In contrast, the depression PRS predicted higher levels of COVID-19 burnout. Anxiety symptoms fully mediated the association between the depression PRS and COVID-19 burnout. Resilience did not moderate this association.
CONCLUSIONS NlmCategory: CONCLUSIONS
Genetic vulnerability to mental disorders has been associated with coronavirus disease-19 (COVID-19) outcomes. We explored whether polygenic risk scores (PRSs) for several mental disorders predicted poorer clinical and psychological COVID-19 outcomes in people with pre-existing depression. Data from three assessments of the Australian Genetics of Depression Study ( = 4405; 52.2 years ± 14.9; 76.2% females) were analyzed. Outcomes included COVID-19 clinical outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and long COVID, noting the low incidence of COVID-19 cases in Australia at that time) and COVID-19 psychological outcomes (COVID-related stress and COVID-19 burnout). Predictors included PRS for depression, bipolar disorder, schizophrenia, and anxiety. The associations between these PRSs and the outcomes were assessed with adjusted linear/logistic/multinomial regressions. Mediation ( = 4338) and moderation ( = 3326) analyses were performed to explore the potential influence of anxiety symptoms and resilience on the identified associations between the PRSs and COVID-19 psychological outcomes. None of the selected PRS predicted SARS-CoV-2 infection or long COVID. In contrast, the depression PRS predicted higher levels of COVID-19 burnout. Anxiety symptoms fully mediated the association between the depression PRS and COVID-19 burnout. Resilience did not moderate this association. A higher genetic risk for depression predicted higher COVID-19 burnout and this association was fully mediated by anxiety symptoms. Interventions targeting anxiety symptoms may be effective in mitigating the psychological effects of a pandemic among people with depression.
DATE PUBLISHED
2024 Nov 18
HISTORY
PUBSTATUS PUBSTATUSDATE
medline 2024/11/18 10:19
pubmed 2024/11/18 10:19
entrez 2024/11/18 04:23
pmc-release 2024/12/17
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Monistrol-Mula A Monistrol-Mula Anna A Department of Medicine, University of Barcelona, Barcelona, Spain.
Felez-Nobrega M Felez-Nobrega Mireia M Centre for Biomedical Research on Mental Health (CIBERSAM), Madrid, Spain.
Byrne EM Byrne Enda M EM Child Health Research Centre, The University of Queensland, Brisbane, Australia.
Lind PA Lind Penelope A PA School of Biomedical Sciences, University of Queensland, Brisbane, Australia.
Hickie IB Hickie Ian B IB Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia.
Martin NG Martin Nicholas G NG Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Medland SE Medland Sarah E SE School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.
Colodro-Conde L Colodro-Conde Lucía L School of Psychology, The University of Queensland, Brisbane, QLD, Australia.
Mitchell BL Mitchell Brittany L BL School of Biomedical Sciences, University of Queensland, Brisbane, Australia.
INVESTIGATORS
JOURNAL
VOLUME: 54
ISSUE: 15
TITLE: Psychological medicine
ISOABBREVIATION: Psychol Med
YEAR: 2024
MONTH: Nov
DAY: 18
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1469-8978
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Psychol Med
COUNTRY: England
ISSNLINKING: 0033-2917
NLMUNIQUEID: 1254142
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
KEYWORD
COVID-19 burnout
COVID-19 outcomes
SARS-CoV-2 infection
anxiety symptoms
depression
genetic vulnerability
mediation analysis
polygenic risk scores (PRS)
resilience
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's